Phlebotomy and erythrocytapheresis
07-2-104
Phase 3 other active
Quick answer
Phlebotomy and erythrocytapheresis for Hereditary Hemochromatosis is a Phase 3 program (other) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Hereditary Hemochromatosis
- Phase
- Phase 3
- Modality
- other
- Status
- active